Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
复制标题
溃疡性结肠炎:一种由遗传(HLA II 类)和亚临床(抗中性粒细胞胞浆抗体)标记物定义的遗传异质性疾病。
DOI:
10.1172/jci116613
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
Targan,SR
中科院分区:
文献类型:
--
作者:
Yang,H;Rotter,JI;Toyoda,H;Landers,C;Tyran,D;McElree,CK;Targan,SR
Newly described distinct associations of HLA class II genes with ulcerative colitis (UC) (DR2) and Crohn's disease (CD) (DR1/DQ5) provide strong evidence for genetic heterogeneity of susceptibility between these two forms of inflammatory bowel disease. A familial distribution of antineutrophil cytoplasmic antibodies (ANCAs, a subclinical marker of UC) in UC families has further implied the existence of heterogeneity within UC. To test the hypothesis that the heterogeneity within UC indicated by ANCAs has a genetic basis that resides within the HLA region, we studied 89 UC cases and an ethnically matched control group (n = 50). Serological and molecular typing techniques were applied to define HLA class II genes (DR, DQ). ANCAs were detected using an enzyme-linked immunosorbent assay, and positive values were confirmed by indirect immunofluorescence. We observed that ANCA-positive UC patients (n = 70) had a significantly increased frequency of DR2 compared with ANCA-negative controls (n = 46) (44% vs 22%, P = 0.01). In contrast, the frequency of DR2 in ANCA-negative UC cases (21%) was virtually identical to that in controls (22%, P = 0.9). Furthermore, the ANCA-negative UC patients had an increase in the DR4 allele compared with ANCA-positive UC (P = 0.004). Thus, with the combination of a subclinical marker (ANCAs) and molecular genetic markers, genetic heterogeneity has been demonstrated within UC: ANCA-positive UC associated with DR2, and ANCA-negative UC likely associated with DR4.
登录
查看更多内容
影响因子:
24.5
作者:
YANG, H;MCELREE, C;ROTTER, JI
通讯作者:
ROTTER, JI
影响因子:
4
作者:
Alan Emery
通讯作者:
Alan Emery
影响因子:
14.2
作者:
SAXON, A;SHANAHAN, F;TARGAN, S
通讯作者:
TARGAN, S
影响因子:
29.4
作者:
Shanahan,F;Duerr,RH;Rotter,JI;Yang,H;Sutherland,LR;McElree,C;Landers,CJ;Targan,SR
通讯作者:
Targan,SR
影响因子:
24.5
作者:
CAMBRIDGE, G;RAMPTON, DS;LEAKER, B
通讯作者:
LEAKER, B